Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
Late gadolinium enhancement (LGE) is the most relevant tool of cardiac magnetic
resonance for tissue characterization, and it plays a pivotal role for diagnostic and …
resonance for tissue characterization, and it plays a pivotal role for diagnostic and …
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association …
B Moura, A Aimo, A Al‐Mohammad… - European Journal of …, 2023 - Wiley Online Library
Left ventricular (LV) hypertrophy consists in an increased LV wall thickness. LV hypertrophy
can be either secondary, in response to pressure or volume overload, or primary, ie not …
can be either secondary, in response to pressure or volume overload, or primary, ie not …
Patterns of replacement fibrosis in hypertrophic cardiomyopathy
J Liu, S Zhao, S Yu, G Wu, D Wang, L Liu, J Song… - Radiology, 2022 - pubs.rsna.org
Background Myocardial replacement fibrosis is one of the major histologic features of
hypertrophic cardiomyopathy (HCM), but its characteristics have not been well delineated …
hypertrophic cardiomyopathy (HCM), but its characteristics have not been well delineated …
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
Aims Sudden cardiac death (SCD) is the most common mode of death in childhood
hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides …
hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides …
Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study
S Greulich, A Seitz, D Herter, F Günther… - European Heart …, 2021 - academic.oup.com
Aims Sudden cardiac death (SCD) is an appalling complication of hypertrophic
cardiomyopathy (HCM). There is an ongoing discussion about the optimal SCD risk …
cardiomyopathy (HCM). There is an ongoing discussion about the optimal SCD risk …
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging
ID Muresan, L Agoston-Coldea - Heart Failure Reviews, 2021 - Springer
Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular disease with
genetic transmission, characterized by the hypertrophy of any segment of the left ventricle …
genetic transmission, characterized by the hypertrophy of any segment of the left ventricle …
Quantitative Late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis
A Kiaos, GN Daskalopoulos, V Kamperidis… - Cardiovascular …, 2024 - jacc.org
Background Quantitative late gadolinium enhancement (LGE) cardiac magnetic resonance
provides important prognostic information for sudden cardiac death (SCD) in hypertrophic …
provides important prognostic information for sudden cardiac death (SCD) in hypertrophic …
Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
EJ Rowin, MS Maron, A Adler, AJ Albano, AM Varnava… - Heart rhythm, 2022 - Elsevier
Background The sudden death (SD) risk stratification algorithm in hypertrophic
cardiomyopathy (HCM) has evolved, underscored recently by novel cardiac magnetic …
cardiomyopathy (HCM) has evolved, underscored recently by novel cardiac magnetic …
Acute clinical presentation of nonischemic cardiomyopathies: Early detection by cardiovascular magnetic resonance
Nonischemic cardiomyopathies include a wide range of dilated, hypertrophic and
arrhythmogenic heart muscle disorders, not explained by coronary artery disease …
arrhythmogenic heart muscle disorders, not explained by coronary artery disease …